Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)

3.950 -0.460 (-10.43%)

Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist

Price and Volume

Volume	1,415,306
Open	4.270
Bid (Size)	4.940 (200)
Ask (Size)	4.990 (200)
Prev. Close	4.410
Today's Range	3.890 - 4.310
52wk Range	3.350 - 16.60
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Postmarket Movers: After-Hours Gainers and Decliners ↗

Today 17:00 EDT

Via Chartmill

Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data

Today 16:05 EDT

From Aardvark Therapeutics, Inc.

Via GlobeNewswire

Performance

52-Week Range 76.2% below 52-week high

3.950

3.3552W Low 16.6052W High

1 Week 13.0% below 1-week high

3.641W Low 4.541W High

Aardvark Therapeutics, Inc. - Common Stock (AARD) traded between $3.35 and $16.60 over the past 52 weeks and last traded at $3.95, 76.2% below its 52-week high. Over the past week it ranged between $3.64 and $4.54.

Past 12 Months

+4.5%

-31.3%

-38.2%

-26.4%

-70.1%

-64.0%

1W +$0.17

1M -$1.80

3M -$2.44

6M -$1.42

YTD -$9.24

1Y -$7.02

AARD was -64.0% over the past year, -26.4% over six months, -70.1% year to date, +4.5% in the last week.

12 Months vs Market

AARD

-64.0%

DIA

+13.3%

SPY

+14.4%

QQQ

+16.3%

IWM

+13.7%

Over the past 12 months AARD returned -64.0% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 9.53× 3-mo avg

Today 1,415,306 3-mo avg 148.5K

374.0K

174.5K

148.5K

207.4K

YTD

230.4K

226.4K

AARD most recently traded 1,415,306 shares against a 3-month average daily volume of 148.5K.

More News

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on

October 21, 2026

From Grabar Law Office

Via GlobeNewswire

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Bank of America Corporation (NYSE: BAC); Coastal Financial Corporation (NASDAQ: CCB); and Erasca, Inc. (NASDAQ: ERAS): Grabar Law Office is Investigating Claims on Your Behalf

October 20, 2026

From Grabar Law Office

Via GlobeNewswire

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Hub Group, Inc. (NASDAQ: HUBG); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims

October 19, 2026

From Grabar Law Office

Via GlobeNewswire

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on

October 15, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); New Era Energy & Digital, Inc. (NASDAQ: NUAI); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is

October 14, 2026

From Grabar Law Office

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

October 13, 2026

From Pomerantz LLP

Via GlobeNewswire

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD

October 13, 2026

From SueWallSt

Via GlobeNewswire

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

October 13, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Levi & Korsinsky Reminds Aardvark Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 13, 2026 - AARD

October 12, 2026

From Levi & Korsinsky, LLP

Via GlobeNewswire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

October 12, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG): Grabar Law Office is Investigating Claims on Your Behalf

October 10, 2026

From Grabar Law Office

Via GlobeNewswire

URGENT AARDVARK DEADLINE: Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th

October 10, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

AARD UPCOMING DEADLINE: Levi & Korsinsky Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm

October 09, 2026

From Levi & Korsinsky, LLP

Via ACCESS Newswire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

October 08, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Erasca, Inc. (NASDAQ: ERAS); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your

October 08, 2026

From Grabar Law Office

Via GlobeNewswire

Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors

October 08, 2026

From Aardvark Therapeutics, Inc.

Via GlobeNewswire

AARD Deadline: Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

October 07, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

October 06, 2026

From Pomerantz LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law

October 06, 2026

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th

October 05, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

If You Lost Money Investing in Aardvark Therapeutics, Inc. (AARD) Contact Robbins LLP for Information About Recovering Your Losses

October 05, 2026

Via Newsfile

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

October 05, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating

October 05, 2026

From Grabar Law Office

Via GlobeNewswire

Frequently Asked Questions

Is Aardvark Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aardvark Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aardvark Therapeutics, Inc. - Common Stock trade on?

Aardvark Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aardvark Therapeutics, Inc. - Common Stock?

The ticker symbol for Aardvark Therapeutics, Inc. - Common Stock is AARD on the Nasdaq Stock Market

What is the current price of Aardvark Therapeutics, Inc. - Common Stock?

The current price of Aardvark Therapeutics, Inc. - Common Stock is 3.950

When was Aardvark Therapeutics, Inc. - Common Stock last traded?

The last trade of Aardvark Therapeutics, Inc. - Common Stock was at 10/22/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.